NATCO PHARMA LTD.
BSE: 524816
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 596.60-2.0% | 608.80+15.1% | 528.80-58.2% | 1.3K+6.0% | 1.2K+3.0% | 1.2K+184.0% | 407.60-68.5% | 1.3K |
| Other Income | 48.30-33.7% | 72.90+31.8% | 55.30-40.7% | 93.30+56.5% | 59.60-4.0% | 62.10-63.0% | 168.00+226.8% | 51.40 |
| Total Income | 644.90-5.4% | 681.70+16.7% | 584.10-57.0% | 1.4K+8.4% | 1.3K+2.7% | 1.2K+111.9% | 575.60-57.2% | 1.3K |
| EXPENSES | ||||||||
| Expenditure | 542.90-5.0% | 571.70+24.6% | 458.90-40.5% | 771.60+8.8% | 709.40+1.5% | 698.70+64.3% | 425.30-22.3% | 547.10 |
| Tax | 27.40+127.5% | -99.60-644.3% | 18.30-78.5% | 85.10+8.0% | 78.80-15.0% | 92.70+265.0% | 25.40-81.3% | 135.80 |
| PROFIT | ||||||||
| PBT | 102.00-7.3% | 110.00-12.1% | 125.20-78.6% | 586.00+7.9% | 542.90+4.2% | 520.80+246.5% | 150.30-81.1% | 796.90 |
| Net Profit | 74.60-64.4% | 209.60+96.1% | 106.90-78.7% | 500.90+7.9% | 464.10+8.4% | 428.10+242.8% | 124.90-81.1% | 661.10 |
| KEY METRICS | ||||||||
| OPM % | 17.77%+2.59pp | 15.18%-7.57pp | 22.75%-20.95pp | 43.70%-1.55pp | 45.25%-3.24pp | 48.49%+64.39pp | -15.90%-70.08pp | 54.18% |
| NPM % | 11.57%-19.18pp | 30.75%+12.45pp | 18.30%-18.60pp | 36.90%-0.16pp | 37.06%+1.96pp | 35.10%+13.40pp | 21.70%-27.49pp | 49.19% |
| EPS | 4.17-64.4% | 11.70+96.0% | 5.97-78.7% | 27.97+8.0% | 25.91+8.4% | 23.90+242.9% | 6.97-81.1% | 36.91 |
Corporate Events
Board MeetingNATCOPHARM
202614Aug
Board Meeting
To consider the Unaudited Financial Results for the quarter …
BSE Filing ↗ Board MeetingNATCOPHARM
20268Jul
Board Meeting
The Board of Directors considered and approved an investment…
BSE Filing ↗ Board MeetingNATCOPHARM
202629May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board MeetingNATCOPHARM
202624Mar
Board Meeting
To consider and approve the Scheme of Arrangement for the de…
BSE Filing ↗ Board MeetingNATCOPHARM
202427May
Board Meeting
Approval of the Audited Financial Results for the quarter an…
BSE Filing ↗ Board MeetingNATCOPHARM
202414Feb
Board Meeting
Consideration of Unaudited Financial Results for the quarter…
BSE Filing ↗ Board MeetingNATCOPHARM
202314Nov
Board Meeting
consideration and approval of The Unaudited Financial Result…
BSE Filing ↗